Frontiers in Public Health (Oct 2023)

Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh

  • Nadim Sharif,
  • Nazmul Sharif,
  • Afsana Khan,
  • Ibrahim F. Halawani,
  • Fuad M. Alzahrani,
  • Khalid J. Alzahrani,
  • Isabel De la Torre Díez,
  • Debora Libertad Ramírez Vargas,
  • Debora Libertad Ramírez Vargas,
  • Debora Libertad Ramírez Vargas,
  • Angel Gabriel Kuc Castilla,
  • Angel Gabriel Kuc Castilla,
  • Angel Gabriel Kuc Castilla,
  • Anowar Khasru Parvez,
  • Shuvra Kanti Dey

DOI
https://doi.org/10.3389/fpubh.2023.1222868
Journal volume & issue
Vol. 11

Abstract

Read online

IntroductionCo-prevalence of long-COVID-19, cardiovascular diseases and diabetes is one of the major health challenges of the pandemic worldwide. Studies on long-COVID-19 and associated health outcomes are absent in Bangladesh. The main aim of this study was to determine the prevalence and impact of long-COVID-19 on preexisting diabetes and cardiovascular diseases (CVD) on health outcomes among patients in Bangladesh.MethodsWe collected data from 3,250 participants in Bangladesh, retrospectively. Multivariable logistic regression model was used to determine the odds ratio between independent and dependent variables. Kaplan-Meier survival curve was used to determine the cumulative survival.ResultsCOVID-19 was detected among 73.4% (2,385 of 3,250) participants. Acute long-COVID-19 was detected among 28.4% (678 of 2,385) and chronic long-COVID-19 among 71.6% (1,707 of 2,385) patients. CVD and diabetes were found among 32%, and 24% patients, respectively. Mortality rate was 18% (585 of 3,250) among the participants. Co-prevalence of CVD, diabetes and COVID-19 was involved in majority of fatality (95%). Fever (97%), dry cough (87%) and loss of taste and smell (85%) were the most prevalent symptoms. Patients with co-prevalence of CVD, diabetes and COVID-19 had higher risk of fatality (OR: 3.65, 95% CI, 2.79–4.24). Co-prevalence of CVD, diabetes and chronic long-COVID-19 were detected among 11.9% patients.DiscussionRisk of hospitalization and fatality reduced significantly among the vaccinated. This is one of the early studies on long-COVID-19 in Bangladesh.

Keywords